BioElectronics Corporation BIEL
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | ||
|---|---|---|---|---|---|
| Revenue | -65.08% | 166.17% | 1,117.11% | 408.04% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -65.08% | 166.17% | 1,117.11% | 408.04% | |
| Cost of Revenue | -31.48% | 147.09% | 1,929.41% | 666.20% | |
| Gross Profit | -89.06% | 176.10% | 767.51% | 262.38% | |
| SG&A Expenses | -104.52% | -14.46% | -8.42% | -3.39% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -68.92% | 0.26% | 52.09% | 51.87% | |
| Operating Income | 79.26% | 97.58% | 89.49% | 80.08% | |
| Income Before Tax | -17.48% | 106.70% | 85.80% | 64.72% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -17.48% | 106.70% | 85.80% | 64.72% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -17.48% | 106.70% | 85.80% | 64.72% | |
| EBIT | 79.26% | 97.58% | 89.49% | 80.08% | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | -- | -- | -- | -- | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | -- | -- | -- | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -0.50% | 4.39% | 4.39% | 4.39% | |
| Average Diluted Shares Outstanding | -0.50% | 4.39% | 4.39% | 4.39% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |